rimonabant improves oxidative/nitrosative stress in mice with nonalcoholic fatty liver disease
Clicks: 121
ID: 188453
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
121 views
20 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #232 of 358 articles by views in journal of aoac international
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 358 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The present study deals with the effects of rimonabant on oxidative/nitrosative stress in high diet- (HFD-) induced experimental nonalcoholic fatty liver disease (NAFLD). Male mice C57BL/6 were divided into the following groups: control group fed with control diet for 20 weeks (C; n=6); group fed with HFD for 20 weeks (HF; n=6); group fed with standard diet and treated with rimonabant after 18 weeks (R; n=9); group fed with HFD and treated with rimonabant after 18 weeks (HFR; n=10). Daily dose of rimonabant (10 mg/kg) was administered to HFR and R group by oral gavage for two weeks. Treatment induced a decrease in hepatic malondialdehyde concentration in HFR group compared to HF group (P<0.01). The concentration of nitrites + nitrates in liver was decreased in HFR group compared to HF group (P<0.01). Liver content of reduced glutathione was higher in HFR group compared to HF group (P<0.01). Total liver superoxide dismutase activity in HFR group was decreased in comparison with HF group (P<0.01). It was found that rimonabant may influence hepatic iron, zinc, copper, and manganese status. Our study indicates potential usefulness of cannabinoid receptor type 1 blockade in the treatment of HFD-induced NAFLD.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (112 words).
Try re-searching for a better abstract.
| Reference Key |
jorgaevi2015oxidativerimonabant
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Bojan Jorgačević;Dušan Mladenović;Milica Ninković;Milena Vesković;Vesna Dragutinović;Aleksandar Vatazević;Danijela Vučević;Rada Ješić Vukićević;Tatjana Radosavljević |
| Journal | journal of aoac international |
| Year | 2015 |
| DOI |
10.1155/2015/842108
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.